Zylox-Tonbridge Hosts Investor Open Day, Showcasing Global Competitiveness
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2h ago
0mins
Source: PRnewswire
- Investor Open Day: Zylox-Tonbridge hosted its Investor Open Day at the Zhuhai Innovation Center, welcoming nearly 150 institutional investors and sell-side analysts, showcasing its global competitiveness and innovation strategy aimed at enhancing market position through R&D-driven innovation and a global manufacturing platform.
- Product Innovation Showcase: The company highlighted its image-guided endovascular therapy platform, including the world's only real-time visualization-guided plaque removal solution, the ZYLOX Pantheris™, marking a significant advancement in precision intervention and elevating global medical standards.
- Accelerated Global Expansion: By the end of 2025, Zylox-Tonbridge established commercial coverage in 83 countries and regions and formed strategic partnerships with over 80 distributors and commercial partners, demonstrating the success of its globalization strategy and market penetration capabilities.
- Sustainable Growth Strategy: The CEO stated that by integrating innovation, industrialized manufacturing, and global commercialization, Zylox-Tonbridge is building a globally competitive vascular intervention platform, with cumulative product use expected to exceed one million procedures by 2025, reflecting strong physician adoption of its technologies.
Analyst Views on 02190
Wall Street analysts forecast 02190 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 02190 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 25.140
Low
Averages
High
Current: 25.140
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
